Cannabis Law Report

OCTOBER 29, 2019

The PK data on cats shows there are differences in absorption between cats and dogs and that dosing may be different between these two species and that our chew form is likely to be more absorbable than oils in general. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.

Safety 45

Safety CBD Clinical Trials Oil 45

The Cannigma

JANUARY 13, 2023

A review of existing endocannabinoid system and migraine research from March 2022 identified many surveys, but fewer clinical research trials, and even fewer double-blind placebo studies. Topical cannabis products can also be useful, but research and data is very limited.

Terpenes 132

Terpenes Strains THC Treatment 132

The Joint Blog

FEBRUARY 24, 2021

Numerous trials have been run using medical marijuana and CBD tinctures to treat or reduce the symptoms of Parkinson’s Disease. This is not the first medicinal trial of its kind. Cannabis and CBD oils have often been used to reduce the effects of epilepsy and several other neurological issues, so why not Parkinson’s?

Treatment 55

Treatment Clinical Trials Collective Patients 55

Greencamp

FEBRUARY 2, 2019

Even though scientific data is still somewhat scarce on this topic, several studies confirm that cannabis directly acts on the cells of the immune system affected by HIV. But I haven’t seen any clinical trials looking at the direct effects of THC on the virus. 2016 ( 3 ). Thames, Zanjbeel Mahmood, Alison C.

Marijuana 110

Marijuana Therapy Cannabinoids Patients 110

Cannabis Law Report

JANUARY 18, 2019

Several of these products have already completed or been approved for clinical trials in Israel. Founded in 2004, TheraCann International Benchmark Corporation offers a one-stop, full-service solution for the International cannabis marketplace. About TheraCann.

Research and Development 40

Research and Development Clinical Trials Extraction Therapy 40

Cannabis Law Report

JULY 12, 2019

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. September 2004. 30 (2): 187–96.(1998).

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73